Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
araboxylan
Sun Yat-sen University
Subjects With Hyperuricemia
1 trial -
atosiban
Hospital Authority, Hong Kong
Repeated Implantation Failure
1 trial -
avatrombopag
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Refractory Aplastic Anemia
1 trial -
bicycle ergometry test with spiroergometry
The First People's Hospital of Lianyungang
Community-acquired Pneumonia
1 trial -
bismuth-containing quadral therapy based on antibiotic susceptibility
Shandong University
Helicobacter Pylori
1 trial -
bitter melon peptides
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes
1 trial -
blood draw from three different vessels
Sionna Therapeutics
Accidental Hypothermia
1 trial -
blood sampling
Marker Therapeutics
Screening for Colon Cancer
1 trial -
blood sampling
Marker Therapeutics
Colorectal Cancer Screening
1 trial -
blood sampling (alpha-Galactosidase & LysoGb3)
Takeda
Fabry Disease
1 trial -
botulinum toxin type A
Ultragenyx UK Limited
Hyperhidrosis
1 trial -
bovine Lactoferrin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nosocomial Infections
1 trial -
bpMRI
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
brachytherapy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
buprenorphine and low-dose naloxone
Indivior Pty Ltd
Pain
1 trial -
carbohydrates
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Insulin Resistance
1 trial -
caspofungin
Beijing Chao Yang Hospital
Pneumocystis Pneumonia
1 trial -
cefditoren pivoxil tablets
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Medication Safety
1 trial -
circulate free methylated EBV DNA
The First People's Hospital of Lianyungang
Extranodal Natural Killer/T-cell Lymphoma
1 trial -
cocaine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Dependence
1 trial -
concentrated growth factor + bone substitute
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Concentrated Growth Factor
1 trial -
cyclosporine
Ultragenyx UK Limited
Metabolism, Inborn Errors
1 trial -
dexmedetomidine
Sana Biotechnology
Laparoscopic Cholecystectomy
1 trial -
erlotinib (Tarceva) and bexarotene (Targretin)
LIGAND PHARMACEUTICALS INC
Carcinoma, Non-small-cell Lung
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources